INS and obesity due to melanocortin 4 receptor deficiency: Both obesity and nonobesity groups showed significant improvements from baseline to endline in weight, BMI, glycemic markers (HbA1c and FBG), fasting insulin, insulin resistance indices (HOMA-IR and QUICKI), blood pressure, and lipid parameters (triglycerides, non-HDL, and HDL-C).